Novavax, Inc. (FRA:NVV1)
Germany
· Delayed Price · Currency is EUR 5.82
0.00 (0.00%)
At close: Dec 4, 2025
Novavax Employees
Novavax had 952 employees as of December 31, 2024. The number of employees decreased by 591 or -38.30% compared to the previous year.
Employees
952
Change (1Y)
-591
Growth (1Y)
-38.30%
Revenue / Employee
€953,153
Profits / Employee
€305,955
Market Cap
965.22M
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Merck KGaA | 59,020 |
| Siemens Healthineers AG | 73,840 |
| Bayer Aktiengesellschaft | 91,864 |
| Fresenius SE & Co. KGaA | 176,486 |
| Sartorius Aktiengesellschaft | 13,528 |
| Fresenius Medical Care AG | 111,513 |
| Carl Zeiss Meditec AG | 5,730 |
| Fielmann Group AG | 24,363 |
Novavax News
- 4 days ago - FDA Plans to Tighten Vaccine Approvals Weigh on These Stocks - Investopedia
- 4 days ago - Vaccine stocks take a hit as FDA official points to link between COVID-19 vaccines and rare heart condition in young men - Market Watch
- 4 days ago - Moderna and Novavax Stocks Drop as FDA Proposes Stricter Vaccine Approvals - Barrons
- 9 days ago - Milestones Over Sales: The Sanofi Partnership Now Drives Novavax's Outlook - Seeking Alpha
- 9 days ago - January 2026 Options Now Available For Novavax (NVAX) - Nasdaq
- 14 days ago - Novavax, UniFirst, and More Stocks See Action From Activist Investors - Barron's
- 14 days ago - Novavax rises after a seven-day slide - Seeking Alpha
- 16 days ago - Notable Wednesday Option Activity: NVAX, BLK, MP - Nasdaq